LLY/long
GLP-1 adoption boosts demand for nutrient-dense food; makers like Eli Lilly ride structural eating shift
About one in five American adults have used (or are using) Ozempic, Wegovy, or a similar medication. GLP-1 users experience a 25 to 40 percent decrease in caloric intake , which means every bite has to count.
Peak+14.4%